Skip to product information
1 of 3

Bbraun

Bbraun Prontosan Advanced Wound Irrigation Solution 40ml (Box of 24s)

Bbraun Prontosan Advanced Wound Irrigation Solution 40ml (Box of 24s)

Regular price $95.90 SGD
Regular price Sale price $95.90 SGD
Sale Sold out
Shipping calculated at checkout.
Clinical Summary: B|Braun Prontosan® Wound Irrigation Solution is a sterile, ready-to-use cleansing solution containing 0.1% polyhexanide (PHMB) and 0.1% betaine surfactant in purified water. It is indicated for the irrigation, cleansing, and moistening of acute and chronic wounds, with action against biofilm and wound debris. Each carton contains 24 single-patient 40 ml rinse bottles for daily wound bed preparation.

Product Overview

Prontosan® is one of the most widely studied wound irrigation solutions in the world, supporting the TIME (Tissue, Infection/inflammation, Moisture, Edge) framework for chronic wound bed preparation as described by Schultz and colleagues and adopted in the EWMA position document on wound bed preparation. The combination of polyhexanide (a broad-spectrum antimicrobial preservative) and betaine (a non-ionic surfactant) physically loosens biofilm and wound debris while reducing the bioburden of organisms encountered in chronic wounds, including MRSA, VRE, Pseudomonas aeruginosa, and yeasts.

The 40 ml format is intended as a daily rinse bottle for use after initial irrigation with the 350 ml bottle, or as a stand-alone cleansing solution for smaller wounds, ostomy peri-stomal skin preparation, or burn-care wash. Each unit is sterile, single-patient use, and ready-to-use without dilution. Supplied 24 bottles per carton with batch and lot traceability.

Specifications

Manufacturer B|Braun Medical (Melsungen, Germany)
Product Prontosan® Wound Irrigation Solution
Active Ingredients 0.1% Polyhexamethylene Biguanide (PHMB / polyhexanide); 0.1% undecylenamidopropyl betaine surfactant
Vehicle Purified water (Aqua purificata)
Volume 40 ml per bottle
Pack Size Carton of 24 bottles
Sterility Sterile, single-patient use; do not re-sterilise
Latex Content Not made with natural rubber latex
Storage Store below 25°C; protect from freezing; once opened, use within 8 weeks
Regulatory CE-marked under EU MDR 2017/745, Class IIb medical device; manufactured under ISO 13485 quality management; HSA Singapore-listed via licensed importer; FDA 510(k) cleared (K081279) for the original Prontosan platform
Compatibility Compatible with negative pressure wound therapy systems and most modern dressings (silicone foam, alginate, hydrofibre)

Clinical Indications

  • Cleansing, irrigation, and moistening of chronic wounds — venous leg ulcers, arterial ulcers, mixed-aetiology ulcers, diabetic foot ulcers, and pressure injuries.
  • Acute wound preparation following debridement, including post-surgical incision care and traumatic wound lavage.
  • First-degree and second-degree burn cleansing as part of routine dressing change protocols.
  • Removal of biofilm and slough as part of TIME-based wound bed preparation prior to advanced dressing application.
  • Decolonisation support for chronic wounds with confirmed bacterial bioburden, including MRSA-positive wounds, in conjunction with antimicrobial stewardship guidance.

Frequently Asked Questions

Q: What is the difference between Prontosan and saline?
A: Saline (0.9% sodium chloride) physically rinses wound surfaces but lacks surfactant action and has no anti-biofilm activity. Prontosan combines a surfactant (betaine) with a preservative antimicrobial (polyhexanide) to disrupt biofilm matrix structure and reduce bioburden, supporting wound bed preparation in chronic and stalled wounds (Wounds International 2010; Wounds UK best practice statement 2017).

Q: How long should the solution remain in contact with the wound?
A: Manufacturer guidance recommends a soak (compress) of 10-15 minutes for biofilm-affected wounds prior to mechanical cleansing. For routine irrigation, the solution is applied and gently wiped or rinsed.

Q: Is Prontosan safe in cavity wounds and over exposed bone or tendon?
A: Prontosan is indicated for use in cavity wounds and is regarded as cytocompatible at recommended concentrations. It should not be injected into deep tissue spaces, peritoneum, central nervous system, or middle/inner ear.

Q: How does the 40 ml bottle differ from the 350 ml bottle?
A: The 350 ml bottle is the primary irrigation format used at the start of a wound care episode for thorough cleansing. The 40 ml rinse bottle is intended for daily wound maintenance and dressing change, providing a sterile single-use volume that supports infection prevention and reduces solution wastage.

Q: How is Prontosan supplied in Singapore?
A: B|Braun Prontosan is HSA-listed and imported into Singapore through licensed medical device distributors. EMIS+ supplies Prontosan to Singapore acute hospitals, polyclinics, community hospitals, and home-care patients with documented batch and lot traceability.

View full details